A month after changing its name from CMT Solutions to careviso, the Falls Church health-tech company has raised $17.4 million in new funding and plans to use the proceeds to add new services and broaden physicians’ and health plans’ access to its tech platform.
The company, which primarily provides technology to help doctors secure insurance coverage for lab tests, said Wednesday that Ballast Point Ventures of Tampa, Florida, led the Series B round and that two existing investors, Houston venture capital firm Mercury and New York’s Lytical Ventures, also participated.
The capital infusion more than doubles the $16.7 million careviso raised in earlier funding rounds in March 2021 and April 2019, and positions the company to “pivot towards a broader part of the diagnostic testing process to solve the growing challenges for patients – reducing complexity and providing a clear picture of costs,” Andrew Mignatti, its co-founder and CEO, said in a statement Wednesday.
Historically,…
Read the full story from the Washington Business Journal.
